Skip to content

Ginkgo Bioworks

US · DNA #3438 by market cap
11.47 -0.94 -7.57%
Live - 5344 symbols - heartbeat 341s ago · 2026-10-08 08:18
Pre-market 11.06 -3.57%
After-hours 11.31 -1.40%
Overnight 11.46 -0.09%
Market cap
772.39M
P/B
1.84
EPS
-5.64
Reader sentiment Are you bullish or bearish on DNA?

Anonymous reader poll. Unscientific, not investment advice.

Ginkgo Bioworks ended the session at 11.47, down 7.57%. The company carries a market value of roughly 772.39M, the #3438 most valuable US-listed company we track. The 3 analysts covering the stock are, on balance, at Sell, targeting an average of 7.00 (-39%). The shares sit 47% of the way up their 52-week range of 5.37 to 18.22.

✦ StockVane Quant Insights how this is computed

Quant Rating D Preliminary
  • Not yet in the StockVane Momentum strategy's universe - this name needs price history back to 2021 for a reliable signal and doesn't have it yet (most often because it IPO'd or was spun off more recently). This grade is a preliminary blend of valuation, momentum and analyst data, not a Momentum buy/sell call.
  • Valuation sits at the 46% percentile of its own 5-year range.
  • Price momentum averages +0.1% across the trailing 3-month/1-year windows.
  • Analyst consensus across 3 analysts is Sell.
Quant Sentiment Bearish
  • Recent price momentum is +0.1% on average (3-month/1-year).
  • Main-fund capital flow has been a net inflow over the last 45 sessions.
  • Short interest has risen to 10.6% of float.
  • Analyst tilt is Sell.
Quant Technical Outlook Bullish
  • Price is above its 20-day average and above its 60-day average.
  • The 20-day average is above the 60-day average, a short-term uptrend.

Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.

Price chart

14.986.4311.472026-04-092026-10-07
MA5MA10MA20MA60
— MA5 — MA10 — MA20 — MA60

Performance

1W -10.60%
1M +65.04%
3M +22.81%
6M +68.18%
YTD +38.03%
1Y -22.60%
3Y -83.33%
5Y -97.44%

Key statistics

Price & volume

Prev close
12.41
Open
11.81
Day range
10.81 - 11.95
Avg price
11.46
Volume
6.46M
Turnover
73.98M
Amplitude
9.16%
52-week range
5.37 - 18.22

Valuation

P/E
-2.03
P/E (TTM)
-2.29
P/B
1.84
EPS
-5.64
Net profit
-379.80M
Net assets
420.27M

Share structure

Market cap
772.39M
Float cap
572.10M
Shares out
67.34M
Float shares
49.88M

Dividend & listing

Dividend (TTM)
0.00
Listing date
--
52-week range 47% of range
5.37 18.22

37.0% below the 52-week high

Trading activity

Net capital flow main funds, last 45 sessions

+498.19K net over the window

Short interest

Shares short
7.17M
As of
2026-09-15

Frequently asked questions

What is the current stock price of Ginkgo Bioworks (DNA)?

Ginkgo Bioworks last traded at 11.47. The quote on this page refreshes every few seconds while US markets are open.

What is Ginkgo Bioworks's market cap?

About 772.39M.

What is the P/E ratio of Ginkgo Bioworks?

The trailing twelve-month P/E is -2.29. The Valuation tab shows it against the stock's own five-year range.

Does Ginkgo Bioworks pay a dividend?

Ginkgo Bioworks does not currently pay a regular dividend.

Is Ginkgo Bioworks a buy according to analysts?

The consensus of 3 analysts is a Sell rating, with an average 12-month price target of 7.00, which implies 39.0% downside from the current price. This is not investment advice.

Quote time 2026-10-08 08:18:36 · For reference only, not investment advice and not tailored to your situation.